EcoDrugPlus

Ensembl ID : ENSMAUG00000009344
Gene Symbol: -
Cross references: -
253 Possible Orthologues:

Ensembl ID : ENSMAUG00000014284
Gene Symbol: -
Cross references: -
137 Possible Orthologues:

Ensembl ID : ENSMAUG00000018923
Gene Symbol: -
Cross references: -
274 Possible Orthologues:

Ensembl ID : ENSMAUG00000011057
Gene Symbol: -
Cross references: -
312 Possible Orthologues:

Ensembl ID : ENSMAUG00000018500
Gene Symbol: -
Cross references: -
149 Possible Orthologues:

Ensembl ID : ENSMAUG00000008123
Gene Symbol: -
Cross references: -
50 Possible Orthologues:

Ensembl ID : ENSMAUG00000012729
Gene Symbol: -
Cross references: -
152 Possible Orthologues:

Ensembl ID : ENSMAUG00000005925
Gene Symbol: -
Cross references: -
64 Possible Orthologues:

Ensembl ID : ENSMAUG00000017719
Gene Symbol: -
Cross references: -
81 Possible Orthologues:

Ensembl ID : ENSMAUG00000007504
Gene Symbol: -
Cross references: -
66 Possible Orthologues:

Ensembl ID : ENSMAUG00000014635
Gene Symbol: -
Cross references: -
185 Possible Orthologues:

Ensembl ID : ENSMAUG00000017764
Gene Symbol: -
Cross references: -
40 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).